Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia

STUDY OBJECTIVES: To evaluate the efficacy and safety of doxepin 1 mg and 3 mg in elderly subjects with chronic primary insomnia. DESIGN AND METHODS: The study was a randomized, double-blind, parallel-group, placebo-controlled trial. Subjects meeting DSM-IV-TR criteria for primary insomnia were rand...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Krystal, Andrew D., Durrence, H. Heith, Scharf, Martin, Jochelson, Philip, Rogowski, Roberta, Ludington, Elizabeth, Roth, Thomas
Format: Artigo
Jezik:Inglês
Izdano: Associated Professional Sleep Societies, LLC 2010
Teme:
Long-Term Safety and Efficacy of Doxepin for Elderly Insomnia
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954705/
https://ncbi.nlm.nih.gov/pubmed/21102997
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items